Sector: Pharmaceuticals

The board believed that the difference between the marks was particularly clear from a semantic point of view, which, in turn, had an impact on the visual and phonetic perception of the marks.

06 February 2023

To complete our latest series of Legal Updates that you may have missed, we highlight takeaways from decisions handed down in the Americas over the past few months.

03 February 2023

WTR sits down with PSI’s Asia-Pacific regional director Ramesh Raj Kishore to look back at the organisation’s journey and forward into the future.

31 January 2023

The word element ‘well’, as regards the part of the relevant public which understands its meaning in English, has a low degree of distinctiveness for goods/services which are connected to a person’s physical wellbeing.

26 January 2023

IP lawyers have expressed their concern after meeting with the new director of the Mexican Institute of Industrial Property, José Sánchez Pérez, to learn about his priorities.

25 January 2023

Featured in Stock market performance

Stock prices had a largely negative December, closing out a rocky year on the stock markets. Our WTR Brand Elite indices fell five points on the month, and 25 points across 2022.

16 January 2023

In two recent unfair competition disputes in Belarus, the anti-monopoly authority has reached contrasting decisions.

13 January 2023

The judgment provides clarity as to what actions may be relied on to counter the defence of acquiescence.

11 January 2023

Amid turmoil in Brazil over the past week, top officials have been swept out of INPI, but local experts expect IP progress to continue.

10 January 2023

The CJEU’s decision in this case - together with the other decisions issued on 17 November 2022 - provides important guidance for trademark owners and parallel importers in the pharmaceutical industry.

10 January 2023